Nosocomial outbreak of ampicillin resistant Enterococcus faecium:: Risk factors for infection and fatal outcome

被引:19
作者
Harthug, S [1 ]
Eide, GE
Langeland, N
机构
[1] Haukeland Hosp, Inst Med, N-5021 Bergen, Norway
[2] Haukeland Hosp, Clin Res Ctr, N-5021 Bergen, Norway
[3] Haukeland Hosp, Sect Med Stat, N-5021 Bergen, Norway
[4] Haukeland Hosp, Ctr Int Hlth, N-5021 Bergen, Norway
关键词
Enterococcus faecium; ampicillin resistance; cephalosporins; disease outbreaks;
D O I
10.1053/jhin.2000.0728
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
A nosocomial outbreak caused by ampicillin resistant Enterococcus faecium (ARE) was detected at a Norwegian university hospital in January 1995. Prior to this outbreak, ARE were not common in this hospital or other hospitals in Norway. During 1995 and 1996, a total of 149 cases with clinical ARE infection were detected prospectively. A case control study was performed by allocating controls matched for gender, age and ward of admission. Altogether, 123 case control pairs with mean age 70.1 years were included. Isolates from 89 (72.4%) of the cases were identical or related to the defined outbreak strain as determined by pulsed-field gel electrophoresis (PFGE). In 75 of the patients (60.9%), ARE caused urinary tract infection, five (4.1%) had bacteraemia, 33 (26.8%) had wound infection and 10 (8.1%) had other infections. In a logistic regression model for 1:1 matched samples, the following factors were identified as significant risk factors for ARE infection: underlying neurological disease (OR = 33.5), prescription of antimicrobial agents for more than 10 days (OR = 8.99), prescription of cephalosporins (OR = 4.69), underlying gastrointestinal disease (OR = 3.36) and length of hospital stay per day (OR = 1.04). The intrahospital death rate for the cases was 18.7% compared with 8.9% for the controls, corresponding to an excess mortality attributable to ARE infection of 9.8%. A history of carbapenem prescription was the only independent factor contributing to death (OR = 5.64) when comparing ARE patients dying in hospital to those surviving. (C) 2000 The Hospital Infection Society.
引用
收藏
页码:135 / 144
页数:10
相关论文
共 42 条
[1]  
[Anonymous], IARC SCI PUBLICATION
[2]  
Bergan T, 1997, SCAND J INFECT DIS, P1
[3]   Risk factors for Clostridium difficile infection [J].
Bignardi, GE .
JOURNAL OF HOSPITAL INFECTION, 1998, 40 (01) :1-15
[4]   EVIDENCE FOR THE GENETIC UNRELATEDNESS OF NOSOCOMIAL VANCOMYCIN-RESISTANT ENTEROCOCCUS-FAECIUM STRAINS IN A PEDIATRIC HOSPITAL [J].
BINGEN, EH ;
DENAMUR, E ;
LAMBERTZECHOVSKY, NY ;
ELION, J .
JOURNAL OF CLINICAL MICROBIOLOGY, 1991, 29 (09) :1888-1892
[5]   The role of "colonization pressure" in the spread of vancomycin-resistant enterococci - An important infection control variable [J].
Bonten, MJM ;
Slaughter, S ;
Ambergen, AW ;
Hayden, MK ;
van Voorhis, J ;
Nathan, C ;
Weinstein, RA .
ARCHIVES OF INTERNAL MEDICINE, 1998, 158 (10) :1127-1132
[6]   EMERGENCE AND NOSOCOMIAL TRANSMISSION OF AMPICILLIN-RESISTANT ENTEROCOCCI [J].
BOYCE, JM ;
OPAL, SM ;
POTTERBYNOE, G ;
LAFORGE, RG ;
ZERVOS, MJ ;
FURTADO, G ;
VICTOR, G ;
MEDEIROS, AA .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (05) :1032-1039
[7]   NOSOCOMIAL ACQUISITION OF BETA-LACTAMASE NEGATIVE, AMPICILLIN-RESISTANT ENTEROCOCCUS [J].
CHIRURGI, VA ;
OSTER, SE ;
GOLDBERG, AA ;
MCCABE, RE .
ARCHIVES OF INTERNAL MEDICINE, 1992, 152 (07) :1457-1461
[8]  
DIXON J, 1992, BMDP STAT SOFTWARE M
[9]   MOLECULAR TYPING OF AMPICILLIN-RESISTANT, NON-BETA-LACTAMASE-PRODUCING ENTEROCOCCUS-FAECIUM ISOLATES FROM DIVERSE GEOGRAPHIC AREAS [J].
DONABEDIAN, SM ;
CHOW, JW ;
BOYCE, JM ;
MCCABE, RE ;
MARKOWITZ, SM ;
COUDRON, PE ;
KURITZA, A ;
PIERSON, CL ;
ZERVOS, MJ .
JOURNAL OF CLINICAL MICROBIOLOGY, 1992, 30 (11) :2757-2761
[10]   DETECTION OF GLYCOPEPTIDE RESISTANCE GENOTYPES AND IDENTIFICATION TO THE SPECIES LEVEL OF CLINICALLY RELEVANT ENTEROCOCCI BY PCR [J].
DUTKAMALEN, S ;
EVERS, S ;
COURVALIN, P .
JOURNAL OF CLINICAL MICROBIOLOGY, 1995, 33 (01) :24-27